Paper Diagnostics Market Scope
The paper diagnostics refers to a cheap sensor technology which diagnosis diseases through colour change reaction. The global paper diagnostics market size is estimated to rise due to changing lifestyle habits, smoking and unhealthy diet coupled with the increased incidence of obesity. Rising need for cost-effective healthcare in remote areas of developing countries is leading to the rising popularity of point-of-care diagnostic methods in these countries.
According to AMA, the Global Paper Diagnostics market is expected to see growth rate of 8.34% and may see market size of USD10.46 Million by 2026.
The Medical Diagnostic Devices have shown a rise in cost due to the complexity of their designs, power consumption and other factors. During the last few years there have been a lot of changes which were made in the area of paper diagnostic. The Advancement of technology and emergence of digitalization in the field of medicine have reduced the time and many traits have unmasked from it. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Paper Diagnostics market throughout the predicted period.
Arkray (Japan), Alere (United States), Bio-Rad Laboratories (United States), Siemens Healthcare (Germany), Acon Laboratories (United States), Abingdon Health (United States), Abcam (United Kingdom), Surmodics (United States), Sigma-Aldrich (Merck Millipore) (United States), Nanohybrids (United States), Innova Biosciences (United Kingdom), Dcn Diagnostics (United States), Cytodiagnostics (Canada) and Chembio Diagnostic Systems (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Sd Biosensor (Republic Of Korea), Bioporto (Denmark) and BBI Solutions (United Kingdom).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
The study have segmented the market of Global Paper Diagnostics market by Type (Lateral Flow Assays, Dipsticks and Paper Based Microfluidics), by Application (Clinical Diagnostics, Food Quality Testing and Environmental Monitoring) and Region with country level break-up.
On the basis of geography, the market of Paper Diagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In August 2018, Constellation Alpha Capital acquires diagnostic chain Medall which is a chain of Medical Diagnostic Service provider.
- Increasing Investments by Government Organizations in R&D Pertaining to The Development of Novel in Vitro Diagnostics Tests and Devices
- Low Cost of Paper Diagnostic Products
- Increasing Prevalence of Diseases such as Cancer, Autoimmune Diseases, and Inflammatory Diseases
- Rising Healthcare Initiatives
- Clinical Development Frameworks of Emerging Economies are Poised to Create Ample Growth
- Low Awareness of This Technique in Emerging Countries
- Lack of Reimbursement
- Dearth of Trained Professionals Limiting the Appropriate Use of Paper Diagnostic
Key Target AudienceHospitals and Clinics, Medical Research and Development (R&D) Companies, Medical Device Companies, Medical Device Manufacturers, Imaging and Diagnostic Centers, Market Research and Consulting Firms, Venture Capitalists and Investors and Others